Union Health Minister Dr. Harsh Vardhan on Wednesday said the government has lifted the time restriction on receiving COVID-19 vaccine jabs, in order to increase the pace of immunization.
People can now get vaccinated round-the-clock according to their convenience, Vardhan said in a tweet, adding that Prime Minister Narendra Modi values the health as well as the time of the citizens of the country.
"The government has lifted the time restriction to increase the speed of vaccination. People can now get vaccinated 24x7 according to their convenience. Prime Minister Narendra Modi understands the value of health as well as the time of citizens," he wrote in Hindi.
Earlier on Tuesday, Union Health Secretary Rajesh Bhushan had said that the timeline of vaccinating the beneficiaries from 9 am to 5 pm has been done away with and it is up to the hospitals to decide whether they want to continue administering the vaccines even after that.
"Co-WIN 2.0 does not provide 9 am-5 pm vaccination sessions. It has done away with that timeline. If a hospital has the capacity, the system permits it to do vaccination even after 5 pm in consultation with the state government.
This has been briefed both to the state governments as well as the private and government hospitals," he had said.
Meanwhile, the second dose of the vaccine against COVID-19 started being administered from February 13 for those who have completed 28 days since the receipt of the first dose. The vaccination of frontline workers (FLWs) began on February 2.
The second phase of the COVID-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions. According to a provisional report till Wednesday 7 am, over 1.56 crore (1,56,20,749) vaccine doses were administered in the country through 3,12,188 sessions.
The beneficiaries include 67,42,187 healthcare workers (first dose), 27,13,144 HCWs (second dose), 55,70,230 FLWs (first dose), 834 FLWs (second dose), 71,896 beneficiaries aged more than 45 years with specific co-morbidities (first dose) and 5,22,458 beneficiaries aged above 60 years.